Skip to main content

Find Clinical Trials

Home
Conditions
Urologic Neoplasms

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 630 recruiting studies

Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Recruiting

PLZ4-Coated Paclitaxel-Loaded Micelles for the Treatment of Patients With Recurrent or Refractory Non-Muscle Invasive Bladder Cancer

NCT06173349

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +16 more
Locations: University of California Davis Comprehensive Cancer Center Sacramento, California, United States

View Trial Details

Recruiting

Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery

NCT07050771

Conditions: Adnexal Diseases, Bladder Cancer, Endocrine Gland Neoplasms, +23 more
Locations: Houston Methodist Neal Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

NCT06349642

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +83 more
Locations: Mayo Clinic in Arizona Phoenix, Arizona, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

Laparoscopic Versus Open Nephrectomy : Clinical Effectivness and Cost Analysis

NCT07461090

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations: Menoufia Faculty of Medicine Shibīn al Kawm, Shebin Elkom, Egypt

View Trial Details

Recruiting

Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer

NCT06488222

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: University of Florida Gainesville, Florida, United States

View Trial Details

Recruiting

68Ga-PSMA PET in the Renal Cell Carcinoma

NCT04987086

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +15 more
Locations: The First Hospital of Lanzhou University Lanzhou, Gansu, China

General Hospital of Ningxia Medical University Yinchuan, Ningxia, China

Qinghai University Affiliated Hospital Xining, Qinghai, China

Xijing Hospital Xi'an, Shaan'xi, China

View Trial Details

Recruiting

Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers

NCT03413982

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: University of Kansas Medical Center Kansas City, Kansas, United States

View Trial Details

Recruiting

Exploration of HRQOL and Urinary Outcomes Following Partial Cystectomy

NCT06891209

Conditions: Bladder Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome

NCT04792463

Conditions: Adenocarcinoma, Adenoma, BAP1 Gene Mutation, +41 more
Locations: The Ohio State University Wexner Medical Center Columbus, Ohio, United States

View Trial Details

Recruiting

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

NCT04075305

Conditions: Bladder Cancer, Bladder Neoplasm, Brain Cancer, +83 more
Locations: Allegheny Health Network Pittsburgh, Pennsylvania, United States

Md Anderson Cancer Center Houston, Texas, United States

Medical College of Wisconsin Milwaukee, Wisconsin, United States

Austin Health - Olivia Newton-John Cancer Wellness and Research Centre Melbourne, Australia

View all 18 locations

View Trial Details